Black Rock Inc. Anixa Biosciences Inc Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Black Rock Inc. holds 160,416 shares of ANIX stock, worth $503,706. This represents 0.0% of its overall portfolio holdings.

Number of Shares

160,416

Previous 154,662 3.72%

Holding current value

$503,706

Previous $482,000 26.56%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.21 - $3.35 $12,716 - $19,275	5,754 Added 3.72%	160,416 $354,000
Q1 2024 May 10, 2024	SELL	$3.08 - $5.02 $6,575 - $10,717	-2,135 Reduced 1.36%	154,662 $482,000
Q4 2023 Feb 13, 2024	SELL	$2.85 - $4.19 $13,591 - $19,982	-4,769 Reduced 2.95%	156,797 $608,000
Q3 2023 Nov 13, 2023	SELL	$2.97 - $3.87 $267,311 - $348,315	-90,004 Reduced 35.78%	161,566 $528,000
Q2 2023 Aug 11, 2023	BUY	$3.0 - $5.97 $12,630 - $25,133	4,210 Added 1.7%	251,570 $805,000
Q1 2023 May 12, 2023	SELL	$3.86 - $5.0 $180,875 - $234,295	-46,859 Reduced 15.93%	247,360 $1.06 Million
Q4 2022 Feb 13, 2023	SELL	$3.78 - $5.81 $12,451 - $19,138	-3,294 Reduced 1.11%	294,219 $1.25 Million
Q3 2022 Nov 14, 2022	BUY	$2.81 - $6.15 $549,644 - $1.2 Million	195,603 Added 191.94%	297,513 $1.46 Million
Q2 2022 Aug 12, 2022	SELL	$2.55 - $4.1 $137 - $221	-54 Reduced 0.05%	101,910 $311,000
Q1 2022 May 12, 2022	SELL	$2.5 - $3.42 $8,010 - $10,957	-3,204 Reduced 3.05%	101,964 $279,000
Q4 2021 Feb 10, 2022	SELL	$2.88 - $5.5 $14,757 - $28,182	-5,124 Reduced 4.65%	105,168 $312,000
Q3 2021 Nov 09, 2021	SELL	$3.57 - $5.6 $27,621 - $43,327	-7,737 Reduced 6.56%	110,292 $525,000
Q2 2021 Aug 11, 2021	BUY	$3.46 - $4.92 $408,380 - $580,702	118,029 New	118,029 $458,000

Others Institutions Holding ANIX

# of Institutions

Shares Held

5.56M

Call Options Held

21K

Put Options Held

6.7K

View Full List

About Anixa Biosciences Inc

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $96.3M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

More about ANIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account